Another strategy showed that Nogo‐A, an axon regeneration inhibitor, is overexpressed in muscles and correlates with disease severity (Jokic et al., 2005) and NMJ denervation (Bruneteau et al., 2015) in ALS patients. The gene discussed is RTN4; the disease is amyotrophic lateral sclerosis.